金萬林-創 News Releases

Kimwanlin Clarifies Media Reports Regarding Company Operations

Kimwanlin Enterprise Co., Ltd. has issued a clarification statement addressing recent media reports … · 2026-06-23

Kim Man Lin - Chuang Invited to TWSE's Innovation Board Company Briefing Session

Kim Man Lin - Chuang has been invited to participate in the corporate briefing session for Innovatio… · 2026-06-19

[Jin Wan Lin - Creation] Announcement: Company Receives Bid for "Whole Genome Sequencing Test Kit Reagent Set" from a National Hospital

Jin Wan Lin (Jin Wan Lin - Creation) has received a bid for the "Whole Genome Sequencing Test Kit Re… · 2026-06-10

Kinmenlin Approves Non-Compete Waiver for Six New Directors at Shareholder Meeting

Kinmenlin approved the waiver of non-compete obligations for six newly appointed directors at the an… · 2026-05-22

【Jin Wan Lin】Announcement of Appointment of Compensation Committee Members upon Expiration of Term

Jin Wan Lin announced on May 22, 115, the appointment of Li Jian-De, Shen Ming-Xin, and Lu Zhi-Yi as… · 2026-05-22

【Jin Wan Lin】Announcement of the Establishment of the Risk Management Committee and Appointment of Members

Jin Wan Lin announced on May 22, 115, the establishment of its Risk Management Committee, appointing… · 2026-05-22

[GeneReach] Announcement of the Board's Appointment of the Chairperson

GeneReach Biotech completed a full board re-election at its annual general meeting on May 22, 115, a… · 2026-05-22

[Golden Biotechnology Corp] Announcement on the full re-election of nine directors at the annual general meeting

Golden Biotechnology Corp held its annual general meeting on May 22, 115, and completed the full re-… · 2026-05-22

【JinWanLin】Announcement of Key Resolutions of the 115th Annual General Shareholders' Meeting

JinWanLin held its annual general shareholders' meeting on May 22, 115, approving the FY114 business… · 2026-05-22

[Jin-Wan-Lin] Announcement of Sustainability Committee Member Re-election due to Expiration of Term

Jin-Wan-Lin Enterprise announced on May 22 that, following the board of directors' re-election, it h… · 2026-05-22

【JinWanLin】Announcement Regarding Changes to the Audit Committee

JinWanLin has reorganized its Audit Committee following the expiration of director terms. Lu Zhi-Yi … · 2026-05-22

【Jin Wan Lin - Chuang】Announcement: The Board of Directors Approved the Consolidated Financial Report for Q1 2026

Jin Wan Lin - Chuang announced that its board of directors approved the consolidated financial repor… · 2026-05-08

【Jin Wan Lin - Chuang】Announcement: The Board of Directors Approved the Consolidated Financial Report for Q1 2026

Jin Wan Lin - Chuang announced that its board of directors approved the consolidated financial repor… · 2026-05-08

[GeneOnLink] May 2026 Revenue Reaches NT$54 Million (Up 40.1% YoY)

GeneOnLink (Code: 6645), a biotechnology and medical company, announced its May 2026 revenue of NT$5… · 2026-05-01

[Jinwanlin-Creation] Announcement of the Company's 2026 First Quarter Financial Report Board Meeting Scheduled for May 8, 2026

Jinwanlin-Creation announced on April 30, 2026, that its board of directors will convene on May 8, 2… · 2026-04-30

[Jinwanlin-Creation] Announcement of the Company's 2026 First Quarter Financial Report Board Meeting Scheduled for May 8, 2026

Jinwanlin-Creation announced on April 30, 2026, that its board of directors will convene on May 8, 2… · 2026-04-30

[Kin Wan Lin] Announcement: Creditor Objection Period for Revised "Domestic First Secured Convertible Bond Issuance and Conversion Method" Has Expired.

Kin Wan Lin Enterprise Co., Ltd. announced that the creditor objection period for its revised conver… · 2026-04-08

[Kin Wan Lin] Announcement: Creditor Objection Period for Revised "Domestic First Secured Convertible Bond Issuance and Conversion Method" Has Expired.

Kin Wan Lin Enterprise Co., Ltd. announced that the creditor objection period for its revised conver… · 2026-04-08

[Jin Wan Lin - Innovation] April 2026 Revenue 35 Million (Year-on-Year -15.5%)

Jin Wan Lin - Innovation (金萬林-創) reported April 2026 revenue of 34.751 million TWD, a decrease of 15… · 2026-04-01

[Jin Wan Lin - Innovation] April 2026 Revenue 35 Million (Year-on-Year -15.5%)

Jin Wan Lin - Innovation (金萬林-創) reported April 2026 revenue of 34.751 million TWD, a decrease of 15… · 2026-04-01

[GeneOn Bio-Creative] March 2026 Revenue NT$0.043B (YoY +14.9%)

GeneOn Bio-Creative, a biotechnology company, announced that its monthly revenue for March 2026 reac… · 2026-03-01

[GeneOn Bio-Creative] March 2026 Revenue NT$0.043B (YoY +14.9%)

GeneOn Bio-Creative, a biotechnology company, announced that its monthly revenue for March 2026 reac… · 2026-03-01

[GeneFirst-Emerging] February 2026 Revenue: NT$36 Million (YoY +12.0%)

GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase y… · 2026-02-01

[GeneFirst-Emerging] February 2026 Revenue: NT$36 Million (YoY +12.0%)

GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase y… · 2026-02-01